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Study of Fresh Microencapsulated Islets With Polylysine-Alginate 
in Xenografts
D. Chen, L. Barneo, M.J. Field, and J.A. van der Viiet
THE use of xenografts is particularly attractive since it would overcome the problem of supply of human 
islets. One intriguing possible approach to the prevention 
of rejection is the encapsulation of islets in a membrane 
that might prevent the entry of killer cells or antibodies, 
and still permit permeability of nutrients and insulin. First 
reports by Lim 1 and O’Shea and Sum2 claimed that 
encapsulated rat islets within a semipermeable membrane 
of cross-linked alginate normalize the diabetic state of 
recipient mice for 80 days. Noticing the islets were cul­
tured in vitro before and/or after microencapsulation in 
this kind of experiment, the objective of the present study 
was to determine whether the capsular membrane of 
cross-linked alginate can isolate the xenograft from the 
host immune system without culture.
MATERIALS AND METHODS 
Animals
Male Lewis rats were used as islet donors, and male BIOBR mice, 
28-32 g, were transplant recipients. The mice were made diabetic 
by injection of streptozotocin (220 mg/kg) intraperitoneally. Only 
mice with plasma glucose concentrations above 350 mg/dL were 
used as recipients. A transplant was considered technically suc­
cessful when the serum glucose was under 200 mg/dL on two 
consecutive occasions at least 24 hours apart,
«
Islet Isolation
Islets were isolated from rat pancreas by ductal collagenase 
distention, stationary digestion, and finally with the aid of dextran 
gradient separation.3
Microencapsulation
The encapsulation method with sodium alginate was similar to 
that described by Lim2 and Goosen et al,4 but using rat fresh 
islets. Briefly, fresh islets from four rat pancreata were suspended 
in 2% (wt/vol) sodium alginate. Spherical droplets containing 
islets were formed by extrusion through a syringe-pump device, 
and collected into a beaker containing 1.3% calcium chloride. 
Gelled droplets were resuspended with 0.6% and 0.3% calcium 
chloride sequentially. Microcapsules were resuspended again in
Table 1. Relationship Between the Morphology of Microcap­
sules With Islets and the Concentration of Alginate Solution
Alginate Concentration Spherical Fraction ol
(%  [wt/vol]) Microcapsules With Islets (%)
1.1 0
1.5 25
2.0 75
2.5 90
3.0 100
Table 2. Effect of Volume of Microcapsules With Islets and Algi­
nate Concentration on Diabetic Mice Mortality
Alginate 
(% {wt/vol])
Volume of Microcapsules With Islets (mL)*
[(no.) %}
0.8 1.0 1.5 2.0
1.5 (0/2) 0 (1/4) 25 (2/2) 100
2.0 (1/10) 10 (1/4) 25 (1/2) 50 (2/2) 100
3.0 (4/4) 100
Note: Mice deaths occurred 1 to 3 days following transplantation. 
'Volume containing 600-1,200 istets.
0.05% polylysine (MW 17,000) for 7 minutes, and washed with
0.1% CHES, followed by an additional wash with 0.15% sodium 
alginate, and then a saline wash. Finally, the capsules were 
resuspended in 1.5% sodium citrate solution for 6 minutes, 
washed in saline, and collected in a syringe, Various concentra­
tions of alginate were tried to make capsules.
Transplantation
The capsules with various volumes and concentrations of alginate 
were transplanted intraperitoneally into diabetic mice to ascertain 
suitable volume and concentration. Between 1,200 and 1,500 islets 
were transplanted into diabetic mice for control. The same 
amount of fresh microencapsulated islets (1.6 to 2.0 mL divided 
two times) were transplanted into group no. 1 (1.5% alginate) or 
group no. 2 (2% alginate).
RESULTS AND DISCUSSION
Theoretically, microencapsulation membrane should be 
semipermeable and biocompatible, it must also be strong 
and durable to prevent the attack of cells and antibodies of 
the recipient. In our experiment, as alginate concentration 
increased more empty capsules became spherical. These 
results were almost the same as Goosen and colleagues’.4 
When capsules were made of 1.5% alginate, 100% of the 
capsules were perfectly spherical and smooth. But, when 
capsules contained islets only 25% of the capsules showed 
a nice sphere, and most of them were oval, irregular, or 
showed tails (Table I). Interestingly, as the alginate con­
centration or volume of capsules transplanted into mice 
increased, the mortality of diabetic mice also increased 
(Table 2). Small amounts of capsules made of 3% alginate
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Table 3. Survival of Xenografts
Group No. No. Mice Survival Days Mean ± SD
Contrai 1,200-1,500 FI 7 3, 3, 4, 5, 7, 7, 8 5.2 ±  1.7
1 1,200-1,500 FMI (1.5%) 8 3, 3, 4, 6, 6 f 8 ,1 0 ,1 2 6.5 ±  3.3
2 1,200-1,500 FMI (2%) 5 2, 3, 4, 4, 4 3.5 ± 1 , 0
FI, fresh islets; FMI, fresh microencapsulated islets in 1.5% or 2.0% alginate.
produced 100% mortality. Therefore, high-concentration 
alginate has a certain harmful effect. So, we chose 1.5% 
and 2.0% alginate to make capsules. Our experiment also 
showed fresh microencapsulated islets could not prevent 
rejection (Table 3). The capsules made of high-concentra­
tion alginate seem to be prone to fibrosis formation so that 
islets died rapidly. The capsules made of low viscosity 
alginate tend to be destructive either in vitro or in vivo,5 so 
that islets were exposed to immune attack.
There are a number of reasons that proved islet xe­
nograft survival is not prolonged by fresh microencapsu­
lated islets. First, the islet immunogenicity was not re­
duced since we did not culture islets. Second, all 
procedures had to be finished so quickly that we could not 
meticulously select healthy islets. The third reason is that 
microencapsular membrane has very poor biocompaiibil- 
ity. We found that Lim and Sum6 cultured microencapsu­
lated islets at 37°C for at least 3 to 4 days before use, 
getting positive results. So, it is suspected that this poly­
electrolyte complex membrane changes its biochemical 
characters in culture media. Therefore, to know the cul­
ture effect on microencapsulation further research will 
have to be done.
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